1. 1) M.J. Stampfer, F.M. Sacks, S. Salvini, W.C. Willett, C.H. Hennekens, A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction, N Engl J Med. 1991; 325: 373-381
2. 2) P.M. Sweetnam, C.H. Bolton, J.W. Yarnell, D. Bainton, I.A. Baker, P.C. Elwood, N.E. Miller, Associations of the HDL2 and HDL3 cholesterol subfractions with the development of ischemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies, Circulation. 1994; 90: 769-774
3. 3) T. Gordon, W.P. Castelli, M.C. Hjortland, W.B. Kannel, T.R. Dawber, High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study, Am J Med. 1997; 62: 707-714
4. 4) D.J. Maron, The epidemiology of low levels of high-density lipoprotein cholesterol in patients with and without coronary artery disease, Am J Cardiol. 2000; 86: 11L-14L
5. 5) R.L. Sacco, R.T. Benson, D.E. Kargman, B. Boden-Albala, C. Tuck, I.F. Lin, J.F. Cheng, M.C. Paik, S. Shea, L. Berglund, High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study, JAMA. 2001; 285: 2729-2735